France· FR:60272948
SOMATOSTATINE VIATRIS 3 mg/1 ml, poudre et solvant pour solution à diluer pour perfusion
A somatostatin product containing somatostatine, registered in France by VIATRIS SANTE. The same ATC class is registered in 7 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Somatostatin is registered in 7 of 19 countries.
Countries holding a registration under ATC H01CB01 (somatostatin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Somatostatin · ATC H01CB01
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Germany
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SOMATOSTATINE
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- H01CB01
- ATC class
- Somatostatin
- Defined daily dose
- 6 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009577141781 flacon(s) en verre de poudre - 1 ampoule(s) en verre de solvant de 1 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Somatostatin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSOMATOSTATINA ACCORD 0.25 mg POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- CzechiaSOMATOSTATIN ARDEZARDEZ Pharma, spol. s r.o., Kosoř
- BelgiumSomatostatine-Belpharma 3 mgEumedica Pharmaceuticals
- GermanySomatostatin InresaInresa Arzneimittel Gmbh
- SwitzerlandStilamin 3 mg, Pulver zur Herstellung einer InfusionslösungHasten Biopharmaceutic (Switzerland) AG
- PolandSomatostatin-EumedicaInPharm Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Somatin, Somatostatin Eumedica
- Belgium · Somatostatine Belpharma, Somatostatine Eumedica
- Bulgaria · Соматостатин Бандалис, Соматостатин Лиомарк
- Cyprus · Somatostatine Eumedica
- Czechia · Somatostatin Eumedica, Somatostatin Rompharm
- Germany · Somatostatin Inresa, Somatostatin Lyomark 3 Mg
- Spain · Somatostatina Gp-Pharm, Somatostatina Normon
- Greece · Atostan, Eklivan
- Italy · Resurmide, Somatostatina Hikma
- Luxembourg · Somatostatine Eumedica, Somatostatine-Eumedica
- Poland · Somatostatin Eumedica
- Portugal · Somatostatina Hikma, Somatostatina Normon
- Romania · Somatostatină Rompharm
- Slovenia · Somatostatin Eumedica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/acbf7969-6fb4-48b9-a93f-389860dc241c GET /v1/drugs/acbf7969-6fb4-48b9-a93f-389860dc241c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60272948",
"date_amm": "2010-05-19",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SOMATOSTATINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about somatostatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.